Literature DB >> 25754871

Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.

Lianping Ti1, Jane Buxton, Scott Harrison, Sabina Dobrer, Julio Montaner, Evan Wood, Thomas Kerr.   

Abstract

BACKGROUND: Despite the reliance on abstinence-based drug policies within hospital settings, illicit drug use is common among hospitalized patients with severe drug addiction. Hospitalized patients who use illicit drugs (PWUDs) have been known to resort to high-risk behavior to conceal their drug use from healthcare providers. Novel interventions with the potential to reduce high-risk behavior among PWUDs in hospital settings have not been well studied.
OBJECTIVE: The objective of the study was to examine factors associated with willingness to access an in-hospital supervised injection facility (SIF).
DESIGN: Data were derived from participants enrolled in 2 Canadian prospective cohort studies involving PWUDs between June 2013 and November 2013. A cross-sectional study surveying various sociodemographic characteristics, drug use patterns, and experiences was conducted.
SETTING: Vancouver, Canada. MEASUREMENTS: Bivariable and multivariable logistic regression analyses were used to explore factors significantly associated with willingness to access an in-hospital SIF.
RESULTS: Among 732 participants, 499 (68.2%) would be willing to access an in-hospital SIF. In multivariable analyses, factors positively and significantly associated with willingness to access an in-hospital SIF included: daily heroin injection (adjusted odds ratio [AOR] = 1.90; 95% confidence interval [CI]: 1.20-3.11); having used illicit drugs in hospital (AOR = 1.63; 95% CI: 1.18-2.26); and having recently used an SIF (AOR = 1.53; 95% CI: 1.10-2.15).
CONCLUSIONS: Our findings highlight the potential of in-hospital SIFs to complement existing harm reduction programs that serve PWUD. Moreover, an in-hospital SIF may minimize the harms associated with high-risk illicit drug use in the hospital.
© 2015 Society of Hospital Medicine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754871      PMCID: PMC4412787          DOI: 10.1002/jhm.2344

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  31 in total

1.  High rates of primary care and emergency department use among injection drug users in Vancouver.

Authors:  T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall
Journal:  J Public Health (Oxf)       Date:  2004-11-25       Impact factor: 2.341

2.  Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Authors:  Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Public Health (Oxf)       Date:  2007-01-17       Impact factor: 2.341

3.  Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs.

Authors:  Ryan McNeil; Will Small; Evan Wood; Thomas Kerr
Journal:  Soc Sci Med       Date:  2014-01-19       Impact factor: 4.634

4.  Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting.

Authors:  Nadia Fairbairn; M-J Milloy; Ruth Zhang; Calvin Lai; Eric Grafstein; Thomas Kerr; Evan Wood
Journal:  J Emerg Med       Date:  2011-06-29       Impact factor: 1.484

5.  HIV and risk environment for injecting drug users: the past, present, and future.

Authors:  Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

6.  Acceptability of a safer injection facility among injection drug users in San Francisco.

Authors:  Alex H Kral; Lynn Wenger; Lisa Carpenter; Evan Wood; Thomas Kerr; Philippe Bourgois
Journal:  Drug Alcohol Depend       Date:  2010-03-19       Impact factor: 4.492

Review 7.  Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review.

Authors:  Leonieke C van Boekel; Evelien P M Brouwers; Jaap van Weeghel; Henk F L Garretsen
Journal:  Drug Alcohol Depend       Date:  2013-03-13       Impact factor: 4.492

8.  Providers' experiences treating chronic pain among opioid-dependent drug users.

Authors:  Karina M Berg; Julia H Arnsten; Galit Sacajiu; Alison Karasz
Journal:  J Gen Intern Med       Date:  2009-02-03       Impact factor: 5.128

9.  Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study.

Authors:  Elisa Lloyd-Smith; Evan Wood; Ruth Zhang; Mark W Tyndall; Sam Sheps; Julio S G Montaner; Thomas Kerr
Journal:  BMC Public Health       Date:  2010-06-09       Impact factor: 3.295

10.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

View more
  8 in total

Review 1.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

2.  Supervised consumption services for acute care hospital patients.

Authors:  Kathryn A Dong; Jennifer Brouwer; Curtis Johnston; Elaine Hyshka
Journal:  CMAJ       Date:  2020-05-04       Impact factor: 8.262

3.  Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.

Authors:  Sandra Cortina; Mary Clare Kennedy; Huiru Dong; Nadia Fairbairn; Kanna Hayashi; M-J Milloy; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2018-06-05

Review 4.  Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.

Authors:  Simeon Kimmel; Paxton Bach; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2020-05-27       Impact factor: 5.128

Review 5.  Supervised injection facilities in Canada: past, present, and future.

Authors:  Thomas Kerr; Sanjana Mitra; Mary Clare Kennedy; Ryan McNeil
Journal:  Harm Reduct J       Date:  2017-05-18

6.  Illicit drug use while admitted to hospital: Patient and health care provider perspectives.

Authors:  Carol Strike; Samantha Robinson; Adrian Guta; Darrell H Tan; Bill O'Leary; Curtis Cooper; Ross Upshur; Soo Chan Carusone
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

7.  Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities.

Authors:  Simeon D Kimmel; Angela R Bazzi; Joshua A Barocas
Journal:  J Subst Abuse Treat       Date:  2020-08-12

8.  Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV.

Authors:  Katherine Rudzinski; Jessica Xavier; Adrian Guta; Soo Chan Carusone; Kenneth King; J Craig Phillips; Sarah Switzer; Bill O'Leary; Rosalind Baltzer Turje; Scott Harrison; Karen de Prinse; Joanne Simons; Carol Strike
Journal:  BMC Public Health       Date:  2021-07-29       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.